Datapult Inc.

Published purpose

Datapult Inc will be developing early diagnosis application and patient management system for a Pharmaceutical company in conjunction with a top American University to obtain timely clinical trial volunteers. The application will enable its participants to track their symptoms and alert them if they meet the symptom threshold to return to the administering pharmacy. This solution will allow the Pharmaceutical company to pin point prospective patients that will have a higher chance of showing positive results to the vaccine for the clinical trial. In turn, increasing the probability that the vaccine in the clinical trial will be approved though the various FDA phases. We will only be providing the software development and patient portal.